|
|
||||||||
Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
LPS binding protein (LBP)4 catalyzes the transfer of LPS to membrane or soluble CD14 (8), which in turn mediates the recognition of LPS through TLR4. The TLR4 signaling complex also requires the small glycosylated protein MD-2 for optimal function (9, 10). The central roles of CD14 and TLR4 in LPS signaling are emphasized by the fact that deficient mice are highly resistant to endotoxic shock (7, 11). In the course of sepsis, physical neutralization (12) and internalization of LPS by immune cells are important for its detoxification; after endocytosis, LPS is biologically deactivated by specific enzymes (13). Various cell surface molecules can bind LPS. In membrane CD14 (mCD14)-positive cells, LPS is internalized via CD14-dependent mechanisms (14, 15, 16), whereas in mCD14-negative cells, like endothelial and epithelial cells, scavenger receptors have been implicated in the clearance of LPS (17, 18, 19). Some recent publications suggest TLR4-dependent LPS internalization and intracellular LPS transport (20, 21, 22). The work by Latz et al. (22) confirmed CD14-dependent LPS uptake as observed earlier (14, 15, 16) and suggests these intracellular TLR4 movements might be transported on lipid rafts along with internalized CD14 (23).
It has been appreciated that TLR4 is a signaling receptor for LPS (7, 24). Although TLR4 is a pattern recognition receptor, like scavenger and mannose receptors (25), its LPS clearance function is unknown. By using primary cells (not transfected cell lines) from TLR4 knockout mice, our data exclude any role for TLR4 as an LPS uptake receptor.
| Materials and Methods |
|---|
|
|
|---|
TLR4/ mice in the C57BL/6 background were obtained from S. Akira (Osaka University, Osaka, Japan). CD14/ mice in the C57BL/6J background were purchased from The Jackson Laboratory (Bar Harbor, ME). All animals were maintained under pathogen-free conditions in a barrier facility (Immunology Vivarium, The Scripps Research Institute), weighed between 20 and 35 g, and were between 6 and 10 wk of age at the time of use.
Mouse monocytes
Halothane-anesthetized C57BL/6 mice were sacrificed and bled by heart puncture. Peripheral blood monocytes were prepared using magnetic cell sorting (MACS; Miltenyi Biotec, Auburn, CA) after isolation of PBMC by density gradient centrifugation over Fico/Lite-LM (Atlanta Biologicals, Norcross, GA). In brief, mononuclear cells were incubated with MACS paramagnetic beads conjugated with monoclonal anti-mouse CD11b, and monocytes were isolated using MS separation columns according to the manufacturers protocol (Miltenyi Biotec). Purity of the preparations usually exceeded 95% as determined by FACS analyses after staining for mouse CD14.
Mouse endothelial cells
Mouse microvascular endothelial cells (MEC) were isolated from lung tissue. Anesthetized animals were sacrificed, and the lungs were explanted under sterile conditions, minced, and digested for 1 h at 37°C in 1 mg/ml collagenase type II in HBSS (Invitrogen Life Technologies, Carlsbad, CA). Cells were separated from debris and incompletely digested tissue with cell strainers, washed twice, and thereafter stained with rat anti-mouse CD31 (10 µg/ml; BD Pharmingen, San Diego, CA). Goat anti-rat IgG conjugated to paramagnetic beads (Miltenyi Biotec) was used for further purification by MACS. Endothelial cells were then cultured and maintained on fibronectin-coated tissue culture plates in mouse brain microvascular growth medium (Cell Application, San Diego, CA) supplemented with 15 ng/ml basic fibroblast growth factor (Sigma-Aldrich, St. Louis, MO). Purity of the cells was >90% as determined by staining for mouse CD31, mouse CD106, or mouse CD144, and by uptake of Alexa Fluor 488-labeled acetylated low-density lipoprotein (Molecular Probes, Eugene, OR). Cells used in experiments were from passages 13.
LPS uptake experiments
Monocytes (1 x 105 cells/ml) were incubated with 100 ng/ml FITC-labeled LPS (Salmonella minnesota Re595; List Biological Laboratories, Campbell, CA) (8) in RPMI 1640 for various time intervals at 37°C. When rLBP was added, this is stated in the figures. MEC were grown to confluence in six-well plates and incubated with 100 ng/ml tritiated LPS ([3H]LPS) (Escherichia coli K12 LCD25; specific activity, 2.08 x 106 dpm/µg; List Biological Laboratories) for 2 h (except in time course experiments) at 37°C along with Abs and human rLBP (26, 27). Anti-LBP (mAb 2B5) and anti-CD14 (mAb 28C5) were produced in our laboratory (28) and have previously been shown to react with bovine LBP and CD14, respectively (26). After incubation, cells were washed twice with PBS and further treated with 250 µg/ml proteinase K (Sigma-Aldrich) in HBSS for 30 min at room temperature to remove cell surface proteins/receptors and surface-bound LPS (29). The remaining LPS was considered to be intracellular. FITC-LPS in monocytes was measured by FACS (given as FL-1 mean channel fluorescence), and counts of [3H]LPS in MEC were assayed in scintillation fluid after lysis of the cells in 300 µl of 2% SDS/50 mM EDTA. To evaluate the participation of scavenger receptors in LPS uptake, cells were pretreated with dextran sulfate (DEX; molecular mass, 8000; 50 µg/ml), polyinosinic acid (PIA; 20 µg/ml), polyadenylic acid (PAA; 20 µg/ml), or polycytidylic acid (PCA; 20 µg/ml) for 30 min before measurement of FITC-LPS uptake or [3H]LPS uptake as described above.
Cell stimulation experiments
Activation of mouse monocytes was measured by MIP-2 secretion. A total of 5 x 104 cells of one well of a 24-well tissue culture plate was stimulated for 4 h at 37°C in RPMI 1640/2% FCS with LPS (E. coli O55:B5; List Biological Laboratories) or the TLR2 agonist macrophage-activating lipopeptide-2 (MALP-2; Alexis Biochemicals, San Diego, CA). Thereafter, supernatants were harvested and assayed for MIP-2 using a commercially available ELISA kit (R&D Systems, Minneapolis, MN).
Immunofluorescence and deconvolution confocal microscopy
Monocytes or MEC derived from TLR4-deficient or control animals were incubated with 1 µg/ml FITC-LPS for 30 min or for 4 h at 37°C. Thereafter, cells were fixed and permeabilized using the Cytofix/Cytoperm kit from BD Pharmingen. mCD14 in monocytes was visualized using anti-CD14 (10 µg/ml; clone rmC5-3; BD Pharmingen) and a matching fluorescent-labeled secondary Ab (Molecular Probes). Cytoskeletal actin filaments were stained with fluorescent phallotoxin (5 µg/ml; Molecular Probes), and nuclei were counterstained with 4',6-diamidino-2-phenylindole (300 nM), before cells were washed and treated with SlowFade Light antifade reagent (Molecular Probes). Images were acquired using the DeltaVision Optical Sectioning Microscope (model 283; Applied Precision, Issaquah, WA). Following data acquisition using the Photometrics (Tucson, AZ) CH350L liquid-cooled charge-coupled device camera, which collects especially low-intensity signals with a linear response to light intensity, the data are then deconvoluted using DeltaVision software SoftWoRx 2.5 (Applied Precision) based on the Agard/Sadat inverse matrix algorithm. This method can combine optical sections (0.15 µm) acquired by a confocal microscope to three-dimensional image stacks. Following computational deconvolution, it can provide high resolution three-dimensional images of cells.
| Results |
|---|
|
|
|---|
LPS uptake was investigated in monocytes and MEC derived from wild-type (wt), TLR4-deficient, or CD14-deficient mice. As expected, CD14-negative monocytes showed a highly impaired LPS uptake with almost no LPS ingestion within 60 min after starting the experiments. In contrast, wt cells did not differ in terms of LPS uptake compared with TLR4-deficient cells (Fig. 1A). In MEC wt cells, LPS uptake was minimal but could be enhanced 10-fold with human LBP (Fig. 1B); this effect was clearly LBP dose dependent (C). No differences in the LPS uptake were found in either genotype of MEC (wt, TLR4/, CD14/). LBP-stimulated uptake in MEC was sensitive to anti-LBP (mAb 2B5) but not to anti-CD14 (mAb 28C5) (Fig. 1, C and D).
|
Monocytes or MEC were pretreated with polyanionic or polycationic substances before LPS uptake was assayed in the presence or absence of human LBP. In the monocytes, LBP-stimulated LPS uptake was inhibited by DEX or PIA only in CD14/ cells; no effect of these scavenger receptor blockers was seen in wt cells. In MEC, dextran and PIA inhibited LBP-stimulated LPS uptake in either genotype tested (wt, TLR4/). The polycations PAA and PCA were not inhibitory in either MEC or monocytes (Fig. 2).
|
TLR4-deficient or wt MEC or monocytes were incubated with FITC-LPS (1 µg/ml) and thereafter investigated by deconvolution microscopy. Neither of the knockout cells showed an altered cellular distribution of LPS when compared with wt cells. In monocytes, FITC-LPS was found both bound to the membrane and intracellularly after 30 min and mostly intracellularly after 4 h (Fig. 3A). In MEC, no membrane localization could be observed and the FITC-LPS was paranuclear by 30 min (Fig. 3B). In both cell types, three-dimensional images clearly revealed intracellular localization of FITC-LPS (not shown).
|
To show full functionality of the cells and to confirm the unique role of TLR4 in LPS signaling, mouse monocytes were stimulated with LPS (E. coli O55:B5; 10 ng/ml) or MALP-2 (1 ng/ml) before MIP-2 levels in the supernatants were measured. As expected, TLR4-negative cells were completely unresponsive to LPS. Responsiveness to MALP-2 was independent of genotype (data not shown).
| Discussion |
|---|
|
|
|---|
As best as we can determine, there are three papers that have approached this question, but none that directly resolved it. Thieblemont et al. (20) studied LPS uptake in peritoneal macrophages from normal and two strains of Lpsd mice, the TLR4-deficient (C57BL/10ScN) and the TLR4-signaling-inactive (C3H/HeJ) mice (7). They observed normal LPS binding to the membranes from all three strains of mice, but observed abnormal intracellular trafficking in the Lpsd macrophages. Normal macrophage LPS uptake in these mice (carrying a TLR4 mutation) does not exclude TLR4 from involvement in LPS uptake, because the defect may only influence TLR4 signaling. C57BL/10ScCr mice are homozygous for a mutant Lps allele (7), resulting in lack of TLR4 mRNA. In connection with LPS, they are therefore very close to TLR4 knockout mice. C57BL/10ScCr dendritic cells and macrophages phagocytose bacteria similarly to control cells, indicating that TLR4 is not compulsory for bacterial uptake (30).
Latz et al. (22) studied uptake of LPS and LPS/CD14 complexes in TLR4-transfected HEK293 cells, but seem not to have studied uptake in nontransfected cells. TLR4 transfection only minimally led to LPS uptake, whereas CD14 cotransfection dramatically improved the ability of those cells to ingest LPS (22). Their results confirmed that mCD14 is an LPS uptake receptor, as known from previous work (14, 15, 16), but their data do not show whether TLR4 has a role in LPS uptake. Transfection of TLR4 into HEK293 cell line (TLR4 negative) might not reveal a role for TLR4 in LPS uptake, because these cells might lack cofactors involved in uptake.
Suzuki et al. (21) showed a correlation between TLR4 expression and LPS uptake in intestinal epithelial cell lines, but did not directly establish a mechanistic connection. Their conclusions are probably based on the observations that IFN-
enhanced TLR4 expression and LPS uptake by Colo205 cells, and that SW480 cells can take up LPS, although they are negative for surface CD14 but positive for surface TLR4. However, TLR4 was not detectable on the surface of Colo205 cells. Compared with these surface CD14-positive cells, SW480 LPS uptake was less and slower in time. According to our results, this would be typical for a scavenger receptor-mediated LPS uptake.
In contrast, our data seem quite clear. Fig. 1 shows that uptake of LPS is quantitatively identical in TLR4 wt and TLR4/ monocytes as well as endothelial cells. Furthermore, as shown in Fig. 3, the TLR4 genotype has no bearing on the intracellular distribution of FITC-LPS. These data leave little room to argue that TLR4 is playing some critical role, either by virtue of acting as a transport protein or by acting as a signal initiating receptor, in either uptake or trafficking of LPS. Moreover, if endothelial cells would express CD14 on their surface, as suggested recently (31), the LPS uptake would follow the pattern observed in wt monocytes; but MEC LPS uptake clearly mimics that seen in CD14/ monocytes.
There is evidence that scavenger receptors can bind not only lipoproteins but also negatively charged phospholipids. Some of these pattern recognition receptors have been demonstrated to directly bind LPS and lipid A (17, 19, 32). Binding of LPS to scavenger receptors can be competed by anionic substances (18). This was also observed in our experiments where LPS uptake in CD14-deficient monocytes and in MEC was sensitive to polyanionic polymers. In terms of LPS uptake, there was no obvious difference between CD14-deficient monocytes and endothelial cells. In both cell types, LPS uptake was slow, stimulated by LBP, and blocked by polyanionic polymers. These findings strongly support the hypothesis that LPS is taken up as an LBP-LPS complex via scavenger receptor-dependent mechanisms in the MEC studied here. Jack et al. (33) have shown that, in LBP/ mice, LPS clearance from the circulation is not affected. This may suggest that MEC uptake of LPS is not quantitatively important in vivo.
In summary, these data support the conclusions that 1) TLR4 plays no role in cellular LPS uptake by monocytes or endothelial cells regardless of their expression of mCD14, 2) these cell types have a scavenger receptor pathway to take up LPS as an LBP complex, and 3) in mCD14-expressing monocytes, there is an additional LPS uptake pathway that is more efficient than the scavenger receptor pathway.
| Footnotes |
|---|
2 This is Publication No. 16304-IMM from The Scripps Research Institute. ![]()
3 Address correspondence and reprint requests to Dr. Peter S. Tobias, Department of Immunology, IMM-12, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037. E-mail address: tobias{at}scripps.edu ![]()
4 Abbreviations used in this paper: LBP, LPS binding protein; mCD14, membrane CD14; MEC, mouse microvascular endothelial cell; DEX, dextran sulfate; PIA, polyinosinic acid; PAA, polyadenylic acid; PCA, polycytidylic acid; MALP-2, macrophage-activating lipopeptide-2; wt, wild type. ![]()
Received for publication December 22, 2003. Accepted for publication May 10, 2004.
| References |
|---|
|
|
|---|
-Interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular Toll-like receptor 4-MD-2 complex. Infect. Immun. 71:3503.This article has been cited by other articles:
![]() |
K. M. Nautiyal, H. McKellar, A.-J. Silverman, and R. Silver Mast cells are necessary for the hypothermic response to LPS-induced sepsis Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2009; 296(3): R595 - R602. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. N. Baranova, R. Kurlander, A. V. Bocharov, T. G. Vishnyakova, Z. Chen, A. T. Remaley, G. Csako, A. P. Patterson, and T. L. Eggerman Role of Human CD36 in Bacterial Recognition, Phagocytosis, and Pathogen-Induced JNK-Mediated Signaling J. Immunol., November 15, 2008; 181(10): 7147 - 7156. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shawkat, R. Karima, T. Tojo, H. Tadakuma, S.-i. Saitoh, S. Akashi-Takamura, K. Miyake, T. Funatsu, and K. Matsushima Visualization of the Molecular Dynamics of Lipopolysaccharide on the Plasma Membrane of Murine Macrophages by Total Internal Reflection Fluorescence Microscopy J. Biol. Chem., August 22, 2008; 283(34): 22962 - 22971. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gong, D. J. Angelini, S. Yang, G. Xia, A. S. Cross, D. Mann, D. D. Bannerman, S. N. Vogel, and S. E. Goldblum TLR4 Signaling Is Coupled to SRC Family Kinase Activation, Tyrosine Phosphorylation of Zonula Adherens Proteins, and Opening of the Paracellular Pathway in Human Lung Microvascular Endothelia J. Biol. Chem., May 9, 2008; 283(19): 13437 - 13449. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-G. Lee, S. Xu, E.-T. Wong, V. Tergaonkar, and K.-P. Lam Bruton's Tyrosine Kinase Separately Regulates NF{kappa}B p65RelA Activation and Cytokine Interleukin (IL)-10/IL-12 Production in TLR9-stimulated B Cells J. Biol. Chem., April 25, 2008; 283(17): 11189 - 11198. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F.-Y. Cheung, C.-K. Wong, W.-K. Ip, and C. W.-K. Lam FAK-mediated activation of ERK for eosinophil migration: a novel mechanism for infection-induced allergic inflammation Int. Immunol., March 1, 2008; 20(3): 353 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-S. Lim, J. M. Timmins, T. A. Seimon, A. Sadler, F. D. Kolodgie, R. Virmani, and I. Tabas Signal Transducer and Activator of Transcription-1 Is Critical for Apoptosis in Macrophages Subjected to Endoplasmic Reticulum Stress In Vitro and in Advanced Atherosclerotic Lesions In Vivo Circulation, February 19, 2008; 117(7): 940 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Petrovan, Y. Yuan, and L. K. Curtiss Expression of the Lystbeige mutation is atheroprotective in chow-fed apolipoprotein E-deficient mice J. Lipid Res., February 1, 2008; 49(2): 429 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
Shuang Chen, M. H. Wong, D. J. Schulte, M. Arditi, and K. S. Michelsen Differential expression of Toll-like receptor 2 (TLR2) and responses to TLR2 ligands between human and murine vascular endothelial cells Innate Immunity, October 1, 2007; 13(5): 281 - 296. [Abstract] [PDF] |
||||
![]() |
P. Ashwood, R. P. H. Thompson, and J. J. Powell Fine Particles That Adsorb Lipopolysaccharide Via Bridging Calcium Cations May Mimic Bacterial Pathogenicity Towards Cells Experimental Biology and Medicine, January 1, 2007; 232(1): 107 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Poupot, L. Griffe, P. Marchand, A. Maraval, O. Rolland, L. Martinet, F.-E. L'Faqihi-Olive, C.-O. Turrin, A.-M. Caminade, J.-J. Fournie, et al. Design of phosphorylated dendritic architectures to promote human monocyte activation FASEB J, November 1, 2006; 20(13): 2339 - 2351. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jozefowski, T. H. Sulahian, M. Arredouani, and L. Kobzik Role of scavenger receptor MARCO in macrophage responses to CpG oligodeoxynucleotides J. Leukoc. Biol., October 1, 2006; 80(4): 870 - 879. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gatti, V. Rivero, R. D. Motrich, and M. Maccioni Prostate epithelial cells can act as early sensors of infection by up-regulating TLR4 expression and proinflammatory mediators upon LPS stimulation J. Leukoc. Biol., May 1, 2006; 79(5): 989 - 998. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. El-Achkar, X. Huang, Z. Plotkin, R. M. Sandoval, G. J. Rhodes, and P. C. Dagher Sepsis induces changes in the expression and distribution of Toll-like receptor 4 in the rat kidney Am J Physiol Renal Physiol, May 1, 2006; 290(5): F1034 - F1043. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pick, C. Perry, T. Lapidot, C. Guimaraes-Sternberg, E. Naparstek, V. Deutsch, and H. Soreq Stress-induced cholinergic signaling promotes inflammation-associated thrombopoiesis Blood, April 15, 2006; 107(8): 3397 - 3406. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Knapp, S. Florquin, D. T. Golenbock, and T. van der Poll Pulmonary Lipopolysaccharide (LPS)-Binding Protein Inhibits the LPS-Induced Lung Inflammation In Vivo. J. Immunol., March 1, 2006; 176(5): 3189 - 3195. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Roes, F. Mumm, U. Seydel, and T. Gutsmann Localization of the Lipopolysaccharide-binding Protein in Phospholipid Membranes by Atomic Force Microscopy J. Biol. Chem., February 3, 2006; 281(5): 2757 - 2763. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gutierrez, E. P. Ratliff, A. M. Andres, X. Huang, W. L. McKeehan, and R. A. Davis Bile Acids Decrease Hepatic Paraoxonase 1 Expression and Plasma High-Density Lipoprotein Levels Via FXR-Mediated Signaling of FGFR4 Arterioscler. Thromb. Vasc. Biol., February 1, 2006; 26(2): 301 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Kitchens and P. A. Thompson Modulatory effects of sCD14 and LBP on LPS-host cell interactions Innate Immunity, August 1, 2005; 11(4): 225 - 229. [Abstract] [PDF] |
||||
![]() |
M. A. Rivieccio, G. R. John, X. Song, H.-S. Suh, Y. Zhao, S. C. Lee, and C. F. Brosnan The Cytokine IL-1{beta} Activates IFN Response Factor 3 in Human Fetal Astrocytes in Culture J. Immunol., March 15, 2005; 174(6): 3719 - 3726. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tunheim, K. W. Schjetne, A. B. Fredriksen, I. Sandlie, and B. Bogen Human CD14 is an efficient target for recombinant immunoglobulin vaccine constructs that deliver T cell epitopes J. Leukoc. Biol., March 1, 2005; 77(3): 303 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Rossi, G. Muralimohan, J. R. Maxwell, and A. T. Vella Staphylococcal enterotoxins condition cells of the innate immune system for Toll-like receptor 4 stimulation Int. Immunol., December 1, 2004; 16(12): 1751 - 1760. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |